SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-24-008425
Filing Date
2024-05-17
Accepted
2024-05-17 17:05:17
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-17

Document Format Files

Seq Description Document Type Size
1 ARS plx-20231231xars.pdf ARS 1909554
  Complete submission text file 0001558370-24-008425.txt   2631297
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33357 | Film No.: 24961170
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)